FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction

"U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Fri, 16 Sep 2016 10:34:23 -0500

Title:     FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction

View as webpage 
News Release
For Immediate Release: Sept. 16, 2016

Media Inquiries: Theresa Eisenman, 301-796-2969, theresa.eisenman@xxxxxxxxxxx   

Consumer Inquiries: 888-INFO-FDA

FDA permits marketing of balloon device to treat persistent Eustachian tube dysfunction
The U.S. Food and Drug
Administration today permitted marketing of a device that uses a small balloon to
treat persistent Eustachian tube dysfunction (ETD), a condition in which
pressure, pain or clogged or muffled sensations occur in the ear.

Read more. 
###

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency is also responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Subscriber Services: 
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)